Max Healthcare Institute Ltd. executed a significant block trade on the National Stock Exchange (NSE), marking notable trading activity in the healthcare sector. The transaction involved substantial share volume and value, reflecting institutional investor interest in the company.

Transaction Details

The block trade encompassed key parameters that highlight the scale of the transaction:

Market Implications

Block trades of this magnitude typically indicate institutional investor activity, as they involve large volumes of shares traded at predetermined prices. The transaction price of Rs. 1095.50 per share provides insight into the current valuation levels at which institutional investors are willing to transact in Max Healthcare Institute's stock.

The Rs. 22.14 crore transaction value demonstrates the significant capital movement in the healthcare sector, particularly in established healthcare service providers. Such block trades often occur when institutional investors are rebalancing portfolios or when there are strategic investment decisions involving substantial stake changes.

Max Healthcare Institute Limited has received significant relief in its GST appeal case, with the tax demand being substantially reduced following a partially favorable order from the Commissioner of Central Tax Appeal-II, Delhi.

Appeal Order Details

The company disclosed receiving the appeal order on February 20, 2026, which provided partial relief from the earlier GST demand. The order relates to alleged discrepancies in Goods and Services Tax provisions involving Input Tax Credit and tax recovery for the period from FY 2017-18 to FY 2020-21.

Significant Reduction in Demand

The appeal has been partly allowed, resulting in a substantial deletion of the original demand. The tax authority deleted GST demand of ₹1,67,32,520, penalty demand of ₹1,68,32,520, and interest demand of ₹27,217 from the original assessment.

Original vs Revised Demand Comparison

Company's Response and Next Steps

Max Healthcare Institute has indicated that the management is in the process of filing a further appeal against the order for the balance GST demand. The company stated that other than the amount to be paid, there is no other impact on the financial, operational, or other activities of the company.

Regulatory Compliance

This disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also hosted this information on its website at www.maxhealthcare.in as part of its transparency and compliance obligations.

The development represents a continuation of the company's earlier intimation dated January 23, 2025, regarding the original GST demand order received on January 22, 2025.